All News

With patient pay responsibility expected to climb 50% of every health care dollar by 2020, solutions to streamlining reimbursement may help.

Lawsuit alleges that patients paid artificially high prices for brand-name Humira, and that they were deprived of the benefits of early, robust competition from biosimilars as a result of wrongful conduct.

According to the report, approximately 80% of new HIV transmissions are from people who do not know they have HIV infection or are not receiving regular care.

Operating a specialty pharmacy is a great benefit to health systems that adopt it early, while those who wait are going to face higher risks and have a lower probability of success.

The phase 3 RELAY trial met its primary endpoint in significantly improving progression-free survival in metastatic EGFR-mutated non-small cell lung cancer.

Top news of the day from across the health care industry.

A simple, compact laser probe is an opportunity for early detection of melanoma, the deadliest form of skin cancer.

Aimmune’s Biologics License Application for AR101 under evaluation as a treatment to reduce the risk of anaphylaxis in peanut-allergic children and adolescents following exposure to peanut.

This therapy is expected to become available in late June.

The framework describes the cyclic nature of medication access, beginning with the patient’s awareness of their illness or condition, and ending with adherence.

Extensive-stage small cell lung cancer is a difficult-to-treat, aggressive type of cancer with limited treatment options.

Specialty therapies for autoimmune diseases and cancer topped the list of biggest-selling drugs for 2018.

Study finds patients with negative beliefs about medications may be more likely to experience adverse effects when taking antiretroviral therapy.

This approval is based on results from the Phase III IMpower133 study, which showed that atezolizumab in combination with chemotherapy helped people live significantly longer compared to chemotherapy alone in the intention-to-treat population.

Top news of the day from across the health care industry.

Levoleucovorin injection is being recalled due to the presence of copper salts discovered during a 12-month stability testing.

As a result of the agreement, Teva is licensed to launch a generic version of liraglutide (Victoza, Novo Nordisk) as of December 22, 2023.

Kaiser Family Foundation analysis examines Medicaid outpatient prescription drug utilization and spending before rebates.

Study finds that hepatocytes cells respond to inflammation by activating a protein that creates the environment needed for cancer cells to spread.

Top news of the day from across the health care industry.

What landed this young man in critical condition, in the burn unit?

A recent study showed that flavonoid-rich cocoa improved fatigue by 45% in patients with relapsing and remitting multiple sclerosis.

Recommendations include adopting a heart healthy diet, engaging in exercise, avoiding tobacco, using aspirin sparingly and managing known risk factors.

Having a healthy gut with the right balance of good bacteria may change the entire health of our bodies.

As part of his guilty plea, Calhoun admitted that he defrauded Medicare Part D of $1.6 million through an elaborate scheme in which he created a fictitious pharmacy on paper called “Cal’s Pharmacy” and used it to process hundreds of prescription claims for drugs that were never dispensed.

Over the last 5 years, post-graduate year-1 (PGY1) residency positions have grown by 34% and post-graduate year-2 (PGY2) positions by 64%.

In the March 15, 2019 FluView update, the CDC reported a slight decrease in the percentage of respiratory specimens testing positive for influenza viruses in clinical laboratories, from the previous week.

A recently presented study indicates that while overall HIV mortality is declining, the rate of opioid overdose deaths in HIV patients is increasing.